NCT03467087View on ClinicalTrials.gov

Safety and Feasibility of Electrical Muscle Stimulation During Stem Cell Transplantation or Intensive Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 3, 2016

Primary Completion Date

February 16, 2017

Study Completion Date

March 16, 2017

Conditions
Electric Stimulation Therapy
Interventions
DEVICE

Myopuls 2000D

Device: Myopuls 2000D (Curatec Services GmBH, 47443 Moers, Germany)

All Listed Sponsors
lead

University Hospital, Saarland

OTHER

NCT03467087 - Safety and Feasibility of Electrical Muscle Stimulation During Stem Cell Transplantation or Intensive Chemotherapy | Biotech Hunter | Biotech Hunter